ROGER GIBSON: Open Payments
NPI 1083681043 · TOPEKA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$878 in 50 payments from 14 companies in 2025. Trend: 2023 $245 · 2024 $849 · 2025 $878
Food & beverage: $878
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $208 |
| Lilly USA, LLC | 7 | $140 |
| Amgen Inc. | 2 | $130 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $93 |
| PFIZER INC. | 3 | $60 |
| Novo Nordisk Inc | 3 | $60 |
| Corium, LLC | 4 | $38 |
| IBSA Pharma Inc. | 2 | $34 |
| Exact Sciences Corporation | 2 | $32 |
| Antares Pharma, Inc. | 1 | $20 |
Products named: UBRELVY, REPATHA, CAPLYTA, JARDIANCE, MOUNJARO, QULIPTA, PREVNAR 20, Ozempic.
Industry payments across KS — which companies pay providers there.
